Log on / register
Feedback | Support | My details
CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E, Wang-Gohrke S, Chang-Claude J
Breast Cancer Res 2005, 7:R455-64
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study
Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crinò L, Barberini F, Rulli A
BMC Cancer 2009, 9:115 (20 April 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Commentary    
CYP17 and breast cancer: no overall effect, but what about interactions?
Little J, Simard J
Breast Cancer Research 2005, 7:238-242 (20 September 2005)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.


Research article    
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
Einarsdóttir K, Rylander-Rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E, Chia KS, Ingelman-Sundberg M, Persson I, Liu J, Hall P, Wedrén S
Breast Cancer Research 2005, 7:R890-R896 (14 September 2005)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.